# Carter BloodCare - Longview – FDA Inspection, Feb 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-longview/9c051c1a-c8ee-45bd-aecb-7c89c255e842
Source feed: FDA_Inspections

> FDA inspection 1262070 of Carter BloodCare - Longview, February 13, 2025. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262070
- Company Name: Carter BloodCare - Longview
- Inspection Date: 2025-02-13
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 0

## Related Documents

- FDA Inspection 1097760 - 2019-06-05
- FDA Inspection 1017197 - 2017-06-23
- FDA Inspection 932717 - 2015-06-17
- FDA Inspection 821700 - 2013-03-05
- FDA Inspection 730855 - 2011-06-21

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/elisa-m-fleming/bfb8308a-9b37-4051-90f2-66066c26e1f4)
- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/carter-bloodcare-longview/4ba0e530-bd97-4236-99fd-e836f706c4ca

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9